186 Results

People

  1. Sadelain
    Sadelain
  2. Perales
    Perales
  3. Giralt
    Giralt
  4. Devlin
    Devlin
  5. Riviere
    Riviere
  6. Brentjens
    Brentjens
  7. Van Den Brink
    Van Den Brink
  8. Dogan
    Dogan
  9. Wang
    Wang
  10. Jakubowski
    Jakubowski

Groups

  1. Hematologic Malignancies, Division of (186)
  2. Department of Medicine (183)
  3. Center for Hematologic Malignancies (169)
  4. GSK Faculty (102)
  5. Sloan Kettering Institute Faculty (83)
  6. Bone Marrow Transplant (70)
  7. Hematologic Malignancies Research (66)
  8. Molecular Pharmacology and Chemistry Program Faculty (53)
  9. Adult Leukemia (46)
  10. Executive Committee, Center for Hematologic Malignancies (40)
  1. "Hematologic Malignancies, Division of"
  2. "Nature Publishing Group"
  3. "Meeting abstract"
Formats
  1. Meeting Abstract (186)
Groups
  1. Hematologic Malignancies, Division of (186)
  2. Department of Medicine (183)
  3. Center for Hematologic Malignancies (169)
  4. GSK Faculty (102)
  5. Sloan Kettering Institute Faculty (83)
  6. Bone Marrow Transplant (70)

More Groups

People
  1. Michel Sadelain (47)
  2. Miguel-Angel Perales (43)
  3. Isabelle Riviere (35)
  4. Sergio Giralt (35)
  5. Sean Devlin (25)
  6. Marcel Van Den Brink (22)

More People

Years
  1. 2023 (20)
  2. 2022 (11)
  3. 2021 (7)
  4. 2020 (26)
  5. 2019 (17)
  6. 2018 (7)

More Years

Publications
  1. Bone Marrow Transplantation (83)
  2. Molecular Therapy (54)
  3. Laboratory Investigation (44)
  4. Cancer Gene Therapy (4)
  5. Clinical Pharmacology & Therapeutics (1)
Publishers
  1. Nature Publishing Group (186)

Results (186)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Optimized double-unit cord blood transplantation mitigates transplant related mortality resulting in high progression-free survival in adults with hematologic malignancies
    Meeting Abstract

    Politikos, I.; Devlin, S.; Chinapen, S.; Quach, S.; Dahi, P.; Gyurkocza, B.; Jakubowski, A.; Papadopoulos, E.; Ponce, D.; Tamari, R.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • A phase 1b study to evaluate the efficacy, safety, and pharmacokinetics of an investigational microbiome therapeutic, SER-155, in adults undergoing hematopoietic stem cell transplantation
    Meeting Abstract

    Tejura, B.; Kosuri, S.; Khera, N.; DeFilipp, M. Z.; Lombardo, M. J.; Ford, C.; Peled, J. U.; van den Brink, M. R. M.; von Moltke, L.; Ponce, D. M.
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Evaluation of urine BKV by day 40 posthematopoietic cell transplant as predictor of BKV-associated hemorrhagic cystitis
    Meeting Abstract

    Lee, Y. J.; Scordo, M.; Glezerman, I.; Han, G.; Perales, M. A.; Giralt, S.; Jakubowski, A.; Papanicolaou, G.
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Initial first-in-human results: CD33-deleted hematopoietic stem and progenitor cells display normal engraftment after hematopoietic cell transplant (HCT) and tolerate post-hct gemtuzumab ozogamicin (GO) without cytopenias
    Meeting Abstract

    Tomlinson, B.; Suh, H. C.; Koura, D.; Koehne, G.; Cho, C.; Bambace, N. M.; Bernard, L.; Shah, N.; Walter, R. B.; DiPersio, J. F.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Access: A multi-center, phase II trial of hlamismatched unrelated donor hematopoietic cell transplantation with post-transplantation cyclophosphamide for patients with hematologic malignancies
    Meeting Abstract

    Al Malki, M. M.; Shaffer, B.; Devine, S. M.; Shaw, B. E.; Broglie, L.; Qayed, M.; Choi, S. W.; Spellman, S. R.; Malmberg, C.; Ndifon, E.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Impact of thiotepa dose-intensity in patients with primary large B-cell lymphoma of the central nervous system (PCNSL) undergoing autologous transplantation (autoHCT) with thiotepa/carmustine (TT-BCNU) conditioning
    Meeting Abstract

    Arshad, S.; Xi, F.; Ahn, K.; Kaur, M.; Scordo, M.; Sauter, C.; Hamadani, M.
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Study design and rationale of stargaze - A phase 2 clinical trial evaluating apraglutide in patients with steroid-refractory gastrointestinal (GI) acute graft-versus-host disease (AGvHD)
    Meeting Abstract

    Zeiser, R.; Perales, M. A.; Adelman, H.; Bolognani, F.; Hockenbery, D.
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Geriatric assessment and outcomes of allogeneic hematopoietic cell transplantation in older patients
    Meeting Abstract

    Dahi, P. B.; Shahrokni, A.; Flynn, J.; Devlin, S. M.; Chinapen, S. A.; Ayala, J.; Brown, S.; Bugen, S.; Cho, C.; Gyurkocza, B.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Outcomes in patients with B-cell precursor acute lymphoblastic leukemia who received inotuzumab ozogamicin and proceeded to hematopoietic stem cell transplantation: A registry-based, observational study
    Meeting Abstract

    Marks, D.; de Lima, M.; Kebriaei, P.; Lanza, F.; Cho, C.; Popradi, G.; Zhang, M. J.; Zhang, F.; Welch, V.; Tikka, S.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Response rates and outcomes in newly-diagnosed multiple myeloma (NDMM) patient subgroups receiving RVd±ASCT plus lenalidomide maintenance until progression in the phase 3 determination trial
    Meeting Abstract

    Hassoun, H.; Jacobus, S. J.; Voorhees, P. M.; Zonder, J. A.; Lonial, S.; Raje, N.; Medvedova, E.; McCarthy, P. L.; Libby, E. N.; Reeves, B.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save